Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7885)
All Articles published online
|
Publishing Process of This Article
|
Sep 14, 2013 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Nicolini D, Svegliati-Baroni G, Candelari R, Mincarelli C, Mandolesi A, Bearzi I, Mocchegiani F, Vecchi A, Montalti R, Benedetti A, Risaliti A, Vivarelli M. Doxorubicin-eluting bead |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i34/5622.htm |
| Number | Citing Articles |
| 1 |
Katerina Malagari, Anastasia Pomoni, Dimitrios Filippiadis, Dimitrios Kelekis. Chemoembolization of hepatocellular carcinoma with HepaSphere™. Hepatic Oncology 2015; 2(2): 147 doi: 10.2217/hep.15.2
|
| 2 |
Ahmed Gabr, Nadine Abouchaleh, Rehan Ali, Michael Vouche, Rohi Atassi, Khairuddin Memon, Ali Al Asadi, Talia Baker, Juan Carlos Caicedo, Kush Desai, Jonathan Fryer, Ryan Hickey, Michael Abeccassis, Ali Habib, Elias Hohlastos, Daniel Ganger, Laura Kulik, Robert J. Lewandowski, Ahsun Riaz, Riad Salem. Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolization. European Journal of Radiology 2017; 93: 100 doi: 10.1016/j.ejrad.2017.05.022
|
| 3 |
Tushar Garg, Apurva Shrigiriwar, Peiman Habibollahi, Mircea Cristescu, Robert P. Liddell, Julius Chapiro, Peter Inglis, Juan C. Camacho, Nariman Nezami. Intraarterial Therapies for the Management of Hepatocellular Carcinoma. Cancers 2022; 14(14): 3351 doi: 10.3390/cancers14143351
|
| 4 |
Antonio Orlacchio, Fabrizio Chegai, Stefano Merolla, Simona Francioso, Costantino Del Giudice, Mario Angelico, Giuseppe Tisone, Giovanni Simonetti. Downstaging disease in patients with hepatocellular carcinoma outside up-to-seven criteria: Strategies using degradable starch microspheres transcatheter arterial chemo-embolization. World Journal of Hepatology 2015; 7(12): 1694-1700 doi: 10.4254/wjh.v7.i12.1694
|
| 5 |
Roberto Mazzanti, Umberto Arena, Renato Tassi. Hepatocellular carcinoma: Where are we?. World Journal of Experimental Medicine 2016; 6(1): 21-36 doi: 10.5493/wjem.v6.i1.21
|
| 6 |
Jean-Luc Raoul, Alejandro Forner, Luigi Bolondi, Tan To Cheung, Roman Kloeckner, Thierry de Baere. Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence. Cancer Treatment Reviews 2019; 72: 28 doi: 10.1016/j.ctrv.2018.11.002
|
| 7 |
Jia-Yan Ni, Lin-Feng Xu, Wei-Dong Wang, Hong-Liang Sun, Yao-Ting Chen. Conventional transarterial chemoembolization <italic>vs</italic> microsphere embolization in hepatocellular carcinoma: A meta-analysis. World Journal of Gastroenterology 2014; 20(45): 17206-17217 doi: 10.3748/wjg.v20.i45.17206
|
| 8 |
Laura Kulik, Riad Salem. Downstaging: Looking for answers, generating more questions?. Liver Transplantation 2015; 21(9): 1117 doi: 10.1002/lt.24209
|
| 9 |
D. A. Chekunov, R. S. Polyakov, N. N. Bagment, Ya. G. Moysyuk, D. N. Fedorov, O. G. Skipenko. Transarterial therapy for hepatocellular cancer. Khirurgiya. Zhurnal im. N.I. Pirogova 2015; (9): 43 doi: 10.17116/hirurgia2015943-49
|
| 10 |
Susan Shamimi-Noori. Contemporary Liver Transplantation. 2017; : 427 doi: 10.1007/978-3-319-07209-8_23
|
| 11 |
Laura M. Kulik, Attasit Chokechanachaisakul. Evaluation and Management of Hepatocellular Carcinoma. Clinics in Liver Disease 2015; 19(1): 23 doi: 10.1016/j.cld.2014.09.002
|
| 12 |
Ender Gunes Yegin, Erkan Oymaci, Emrah Karatay, Ahmet Coker. Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment. Hepatobiliary & Pancreatic Diseases International 2016; 15(3): 234 doi: 10.1016/S1499-3872(16)60097-8
|
| 13 |
Biao Yang, Jie Liang, ZiYu Qu, FangYun Yang, ZhengYin Liao, HongFeng Gou, Gianfranco D. Alpini. Transarterial strategies for the treatment of unresectable hepatocellular carcinoma: A systematic review. PLOS ONE 2020; 15(2): e0227475 doi: 10.1371/journal.pone.0227475
|
| 14 |
Kohei Ogawa, Yasutsugu Takada. Role of Pretransplant Treatments for Patients with Hepatocellular Carcinoma Waiting for Liver Transplantation. Cancers 2022; 14(2): 396 doi: 10.3390/cancers14020396
|
| 15 |
Zhao-Dan Ye, Li Zhuang, Meng-Chen Song, Zhe Yang, Wu Zhang, Jing-Feng Zhang, Guo-Hong Cao. Drug-eluting bead transarterial chemoembolization as neoadjuvant therapy pre-liver transplantation for advanced-stage hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2024; 16(6): 2476-2486 doi: 10.4251/wjgo.v16.i6.2476
|
| 16 |
Susan Shamimi-Noori. Contemporary Liver Transplantation. 2016; : 1 doi: 10.1007/978-3-319-05543-5_23-1
|
| 17 |
Michele Costa de Oliveira Ribeiro, Kerolyn Adorne Moda, Matheus Alvarez, Katia Hiromoto Koga, Sônia Marta Moriguchi, Fábio Cardoso Carvalho, Rafael Soares Nunes Pinheiro, Xingshun Qi, Fernando Gomes Romeiro. Objective Tumor Response of Hepatocellular Carcinoma Obtained by Transarterial Radioembolization with Iodine-131-Lipiodol Versus Transarterial Chemoembolization for Patients with and without Portal Venous Thrombosis: A Controlled Interventional Trial. Academic Radiology 2024; 31(5): 1839 doi: 10.1016/j.acra.2023.10.029
|
| 18 |
Adriana Toro, Gaetano Bertino, Maria Concetta Arcerito, Maurizio Mannnino, Annalisa Ardiri, Domenico Patane’, Isidoro Di Carlo. A Lethal Complication after Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma. Case Reports in Surgery 2015; 2015: 1 doi: 10.1155/2015/873601
|
| 19 |
B. I. Dolgushin, E. R. Virschke, Yu. V. Buydenok, I. V. Pogrebnyakov, N. A. Peregudov, D. Yu. Frantsev. Results of Application of Saturable Microspheres of Domestic Production in Locoregional Endovascular Treatment of Inoperable Patients with Malignant Liver Tumors. Journal of oncology: diagnostic radiology and radiotherapy 2022; 5(4): 96 doi: 10.37174/2587-7593-2022-5-4-96-106
|
| 20 |
Merel van Elk, Burcin Ozbakir, Angelique D. Barten-Rijbroek, Gert Storm, Frank Nijsen, Wim E. Hennink, Tina Vermonden, Roel Deckers, Bing Xu. Alginate Microspheres Containing Temperature Sensitive Liposomes (TSL) for MR-Guided Embolization and Triggered Release of Doxorubicin. PLOS ONE 2015; 10(11): e0141626 doi: 10.1371/journal.pone.0141626
|
| 21 |
Kenji Ikeda. Recent advances in medical management of hepatocellular carcinoma. Hepatology Research 2019; 49(1): 14 doi: 10.1111/hepr.13259
|
| 22 |
Renumathy Dhanasekaran, Julie K. Heimbach. Liver Transplantation for Hepatocellular Carcinoma. Current Transplantation Reports 2014; 1(4): 215 doi: 10.1007/s40472-014-0028-3
|
| 23 |
Liqing Zhang, Zhaodan Ye, Liren Lu, Jianfeng Xu. Is DEB-TACE as locoregional therapy before liver transplantation for hepatocellular carcinoma effective?. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03434-1
|
| 24 |
Carlo Spreafico, Tommaso Cascella, Antonio Facciorusso, Carlo Sposito, Lanocita Rodolfo, Carlo Morosi, Enrico M. Civelli, Marta Vaiani, Sherrie Bhoori, Alessandro Pellegrinelli, Alfonso Marchianò, Vincenzo Mazzaferro. Transarterial Chemoembolization for Hepatocellular Carcinoma with a New Generation of Beads: Clinical–Radiological Outcomes and Safety Profile. CardioVascular and Interventional Radiology 2015; 38(1): 129 doi: 10.1007/s00270-014-0907-0
|
| 25 |
Tengfei Si, Yongjun Chen, Di Ma, Xiaoyong Gong, Ruoyu Guan, Boyong Shen, Chenghong Peng. Transarterial chemoembolization prior to liver transplantation for patients with hepatocellular carcinoma: A meta‐analysis. Journal of Gastroenterology and Hepatology 2017; 32(7): 1286 doi: 10.1111/jgh.13727
|
| 26 |
Thomas J Byrne, Jorge Rakela. Loco-regional therapies for patients with hepatocellular carcinoma awaiting liver transplantation: Selecting an optimal therapy. World Journal of Transplantation 2016; 6(2): 306-313 doi: 10.5500/wjt.v6.i2.306
|
| 27 |
Alberto Unzueta, Roniel Cabrera. Treatment Options in Patients Awaiting Liver Transplantation with Hepatocellular Carcinoma and Cholangiocarcinoma. Clinics in Liver Disease 2017; 21(2): 231 doi: 10.1016/j.cld.2016.12.002
|
| 28 |
Farshad Ramazani, Cornelis F. van Nostrum, Gert Storm, Fabian Kiessling, Twan Lammers, Wim E. Hennink, Robbert J. Kok. Locoregional cancer therapy using polymer-based drug depots. Drug Discovery Today 2016; 21(4): 640 doi: 10.1016/j.drudis.2016.02.014
|
| 29 |
Filipe Veloso Gomes, João A. Oliveira, Mariana Tomé Correia, Nuno Vasco Costa, João Abrantes, Daniel Torres, Pedro Pereira, Ana Isabel Ferreira, José Hugo Luz, Erik Spaepen, Tiago Bilhim, Élia Coimbra. Chemoembolization of Hepatocellular Carcinoma with Drug-Eluting Polyethylene Glycol Embolic Agents: Single-Center Retrospective Analysis in 302 Patients. Journal of Vascular and Interventional Radiology 2018; 29(6): 841 doi: 10.1016/j.jvir.2018.02.004
|
| 30 |
Al B. Benson, Michael I. D’Angelica, Daniel E. Abbott, Daniel A. Anaya, Robert Anders, Chandrakanth Are, Melinda Bachini, Mitesh Borad, Daniel Brown, Adam Burgoyne, Prabhleen Chahal, Daniel T. Chang, Jordan Cloyd, Anne M. Covey, Evan S. Glazer, Lipika Goyal, William G. Hawkins, Renuka Iyer, Rojymon Jacob, R. Kate Kelley, Robin Kim, Matthew Levine, Manisha Palta, James O. Park, Steven Raman, Sanjay Reddy, Vaibhav Sahai, Tracey Schefter, Gagandeep Singh, Stacey Stein, Jean-Nicolas Vauthey, Alan P. Venook, Adam Yopp, Nicole R. McMillian, Cindy Hochstetler, Susan D. Darlow. Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 2021; 19(5): 541 doi: 10.6004/jnccn.2021.0022
|
| 31 |
Antonio Facciorusso, Raffaele Licinio, Nicola Muscatiello, Alfredo Di Leo, Michele Barone. Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients. World Journal of Hepatology 2015; 7(16): 2009-2019 doi: 10.4254/wjh.v7.i16.2009
|
| 32 |
Thierry de Baere, Lambros Tselikas, Frederic Deschamps, Valerie Boige, Michel Ducreux, Antoine Hollebecque. Advances in transarterial therapies for hepatocellular carcinoma: is novel technology leading to better outcomes?. Hepatic Oncology 2016; 3(2): 109 doi: 10.2217/hep-2015-0001
|
| 33 |
ZONGQUAN XU, CHEN YU, SHUFANG WANG, GUOHUI XU. Transcatheter arterial chemoembolization as an examination method for hepatocellular carcinoma undetected by B-mode ultrasound, computed tomography and digital subtratcion angiography: A case report. Oncology Letters 2015; 10(3): 1759 doi: 10.3892/ol.2015.3446
|
| 34 |
Giorgio Greco, Tommaso Cascella, Antonio Facciorusso, Roberto Nani, Rodolfo Lanocita, Carlo Morosi, Marta Vaiani, Giuseppina Calareso, Francesca G Greco, Antonio Ragnanese, Marco A Bongini, Alfonso V Marchianò, Vincenzo Mazzaferro, Carlo Spreafico. Transarterial chemoembolization using 40 µm drug eluting beads for hepatocellular carcinoma. World Journal of Radiology 2017; 9(5): 245-252 doi: 10.4329/wjr.v9.i5.245
|
| 35 |
Laura Kulik, Julie K. Heimbach, Feras Zaiem, Jehad Almasri, Larry J Prokop, Zhen Wang, M. Hassan Murad, Khaled Mohammed. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta‐analysis. Hepatology 2018; 67(1): 381 doi: 10.1002/hep.29485
|
| 36 |
Gustavo Pilotto Domingues Sá, Jorge Roberto Marcante Carlotto, Fernando Pompeu Piza Vicentine, Luiz Romero, Dario Fernandes Perdomo Tejada, Alcides Augusto Salzedas Netto, Gaspar de Jesus Lopes Filho, Adriano Miziara Gonzalez. Avaliação do tratamento dos nódulos do hepatocarcinoma nos pacientes em lista de espera para transplante hepático. Revista do Colégio Brasileiro de Cirurgiões 2017; 44(4): 360 doi: 10.1590/0100-69912017004010
|
| 37 |
Assaf Moore, Michal Cohen-Naftaly, Anna Tobar, Yulia Kundel, Ofer Benjaminov, Marius Braun, Assaf Issachar, Eytan Mor, Michal Sarfaty, Dimitri Bragilovski, Ran Ben Hur, Noa Gordon, Salomon M. Stemmer, Aaron M. Allen. Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma. Radiation Oncology 2017; 12(1) doi: 10.1186/s13014-017-0899-4
|
| 38 |
Joel P. Wedd, Scott W. Biggins. Zakim and Boyer's Hepatology. 2018; : 737 doi: 10.1016/B978-0-323-37591-7.00050-1
|
| 39 |
Merel van Elk, Cyril Lorenzato, Burcin Ozbakir, Chris Oerlemans, Gert Storm, Frank Nijsen, Roel Deckers, Tina Vermonden, Wim E. Hennink. Alginate microgels loaded with temperature sensitive liposomes for magnetic resonance imageable drug release and microgel visualization. European Polymer Journal 2015; 72: 620 doi: 10.1016/j.eurpolymj.2015.03.013
|
| 40 |
Tao Han, Xiaodan Yang, Yue Zhang, Gao Li, Lu Liu, Tingsong Chen, Zhendong Zheng. The clinical safety and efficacy of conventional transcatheter arterial chemoembolization and drug-eluting beads-transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A meta-analysis. BioScience Trends 2019; 13(5): 374 doi: 10.5582/bst.2019.01153
|
| 41 |
Stacey Prenner, Laura Kulik. Zakim and Boyer's Hepatology. 2018; : 668 doi: 10.1016/B978-0-323-37591-7.00046-X
|
| 42 |
Florentina Pascale, Jean-Pierre Pelage, Michel Wassef, Saïda H. Ghegediban, Jean-Pierre Saint-Maurice, Thierry De Baere, Alban Denys, Rafael Duran, Frédéric Deschamps, Olivier Pellerin, Noboru Maeda, Alexandre Laurent, Julien Namur. Rabbit VX2 Liver Tumor Model: A Review of Clinical, Biology, Histology, and Tumor Microenvironment Characteristics. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.871829
|
| 43 |
Amar Karalli, Johan Teiler, Mojgan Haji, Elin Seth, Torkel B. Brismar, Staffan Wahlin, Rimma Axelsson, Per Stål. Comparison of lipiodol infusion and drug-eluting beads transarterial chemoembolization of hepatocellular carcinoma in a real-life setting. Scandinavian Journal of Gastroenterology 2019; 54(7): 905 doi: 10.1080/00365521.2019.1632925
|
| 44 |
Marta Guerrero-Misas, Manuel Rodríguez-Perálvarez, Manuel De la Mata. Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation. World Journal of Hepatology 2015; 7(4): 649-661 doi: 10.4254/wjh.v7.i4.649
|
| 45 |
Yang Jun Kang, Byung Chan Lee, Jae Kyu Kim, Nam Yeol Yim, Hyoung Ook Kim, Soo Buem Cho, Yong Yeon Jeong. Conventional Versus Small Doxorubicin-eluting Bead Transcatheter Arterial Chemoembolization for Treating Barcelona Clinic Liver Cancer Stage 0/A Hepatocellular Carcinoma. CardioVascular and Interventional Radiology 2020; 43(1): 55 doi: 10.1007/s00270-019-02349-9
|
| 46 |
P. Fitzmorris, M. Shoreibah, B. S. Anand, A. K. Singal. Management of hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2015; 141(5): 861 doi: 10.1007/s00432-014-1806-0
|
| 47 |
Antonio Facciorusso, Marianna Di Maso, Nicola Muscatiello. Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysis. Digestive and Liver Disease 2016; 48(6): 571 doi: 10.1016/j.dld.2016.02.005
|
| 48 |
Susan Shamimi-Noori. Contemporary Liver Transplantation. 2016; : 1 doi: 10.1007/978-3-319-05543-5_23-2
|